PsychU

Live Event - All Hands On Deck In The Treatment Of Major Depressive Disorder (MDD): A Focus On Measurement-Based Care In Psychiatry & Primary Care
2022-10-11 18:30 - 20:30 (America/New_York) | Ruth’s Chris Steak House – Manhattan, 148 West 51st Street, Manhattan, NY, 10019, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in New York City, Westchster, and Long Island, NY.

Given the current state of affairs, primary care providers are increasingly treating patients with Major Depressive Disorder (MDD). During this panel presentation, our speakers will be discussing the prevalence and burden of MDD and the impact of COVID-19 on MDD. Additionally, they will discuss barriers faced by primary care providers and include the perspectives and expertise from psychiatrists. Finally, the presenters will consider the potential role of measurement-based care, focusing on the strategies incorporated in their practices and discussing methods of collaboration.

Objectives:

Discuss the prevalence and burden of Major Depressive Disorder (MDD) locally and nationally, including the impact of COVID-19
Identify gaps between primary care and psychiatry within treatment of MDD
Understand the potential role and importance of measurement-based care (MBC)
Consider methods of collaboration that may improve outcomes for patients with MDD

Venue

Featuring

Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

More

Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”

Darcy Leon, PMHNP-BC
Psychiatric Nurse Practitioner

More

Darcy Leon is a psychiatric nurse practitioner currently working in outpatient psychiatry in Tarrytown, NY. She specializes in the treatment of mood disorders, traumatic brain injury, substance use disorders, and treatment-refractory psychiatric illnesses. Darcy also has a specific interest in psychodynamic psychopharmacology, which she employs to better connect patients with the ways their personal experiences interact with medication treatments.

C. Brendan Montano, MD, PC
Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut

More

Brendan Montano, MD, is the owner and medical director of Montano Wellness, LLC, and director of and a principal investigator for CT Clinical Research, all in Cromwell, Connecticut. Dr Montano is also an attending physician at Middlesex Memorial Hospital in Middletown, Connecticut, a clinical instructor at Springfield College in Springfield, Massachusetts, and a primary care section advisor online for PsychU. He earned his medical degree from Albany College in Albany, New York. He completed his residency in internal medicine at Saint Francis Hospital and Medical Center in Hartford, Connecticut. Dr Montano has served as a principal investigator for over 120 clinical trials to evaluate the safety and efficacy of novel therapeutics for indications such as attention-deficit/hyperactivity disorder, major depressive disorder, and many other psychiatric and neurologic conditions. He is an editorial board member of The Primary Care Companion for CNS Disorders.

Michael Townsend, MA, LSW/LCSW
Deputy Chief Executive Officer, Gateway Counseling Center

More

Mr. Townsend, is the Deputy Chief Executive Officer at Gateway Counseling Center where he assists the Chief Executive Officer (CEO) with managing and directing the organization towards its primary objectives, serves as a member of the Boardof Directors, as well as the Chair of Audit Committee of the Mental Health Association in New York, and is also the President of GCC Transportation, LLC, which directs transportation services to the transit disabled and medically frail.

Jehan Marino, PharmD, BCPP
Medical Science Director

Erika Modh, PharmD, BCPS
Medical Science Liaison

Speakers Joseph Goldberg, MD; Darcy Leon, PMHNP-BC; C. Brendan Montano, MD, PC; and Michael Townsend, MA, LCSW are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.Speakers Jehan Marino, PharmD, BCPP and Erika Modh, PharmD, BCPS are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Live Event - Mental Health Awareness: A Focus on Healthcare Professional Risk Of Suicide & Stigma
2022-10-10 18:30 - 20:00 (America/North_Dakota/New_Salem) | RPM Seafood, 317 N Clark St, Chicago, IL, 60654, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in the Chicago, Ill area.
In this presentation, the objectives are to:

Discuss burnout among health care providers & impact on personal and professional outcomes
Explore a stress continuum model and sources of stress
Explore strategies for healthcare professionals to establish & maintain mental health wellness, build resilience, and maintain self-care during times of crisis

Venue

Featuring

Heather Fields, PharmD, MPH, BCACP (OPDC)
Medical Science Liaison

Speaker Heather Fields, PharmD, MPH, BCACP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Live Event - The Role Of Nurses In Reducing Stigma Associated With Mental Health Conditions
2022-10-05 18:30 - 20:00 (America/North_Dakota/New_Salem) | RPM Seafood, 317 N Clark St, Chicago, IL, 60654, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in the Chicago, IL. area.
In this presentation, the objectives are to:

Discuss the impact of stigma associated with mental illness
Review ways nurses can actively address stigma
Questions and discussion

Venue

Featuring

Heather Fields, PharmD, MPH, BCACP (OPDC)
Medical Science Liaison

Speaker Heather Fields, PharmD, MPH, BCACP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Live Event - All Hands On Deck In The Treatment Of Major Depressive Disorder (MDD): A Focus On Measurement-Based Care In Psychiatry & Primary Care
2022-09-29 18:00 - 20:30 (America/New_York) | Ruth’s Chris Steak House – Newington, 2513 Berlin Turnpike, Newington, CT, 06111, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in Connecticut.

Given the current state of affairs, primary care providers are increasingly treating patients with Major Depressive Disorder (MDD). During this panel presentation, Drs. Joseph Goldberg, and C. Brendan Montano will be discussing the prevalence and burden of MDD within the Tri-State region, with an emphasis on Connecticut, and the impact of COVID-19 on MDD. Additionally, the speakers will discuss barriers faced by primary care providers and include the perspectives and expertise from psychiatrists. Finally, the presenters will consider the potential role of measurement-based care, focusing on the strategies incorporated in their practices and discussing methods of collaboration.

Objectives:

Discuss the prevalence and burden of Major Depressive Disorder (MDD) locally and nationally, including the impact of COVID-19
Identify gaps between primary care and psychiatry within treatment of MDD
Understand the potential role and importance of measurement-based care (MBC)
Consider methods of collaboration that may improve outcomes for patients with MDD

Venue

Featuring

Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

More

Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”

C. Brendan Montano, MD, PC
Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut

More

Brendan Montano, MD, is the owner and medical director of Montano Wellness, LLC, and director of and a principal investigator for CT Clinical Research, all in Cromwell, Connecticut. Dr Montano is also an attending physician at Middlesex Memorial Hospital in Middletown, Connecticut, a clinical instructor at Springfield College in Springfield, Massachusetts, and a primary care section advisor online for PsychU. He earned his medical degree from Albany College in Albany, New York. He completed his residency in internal medicine at Saint Francis Hospital and Medical Center in Hartford, Connecticut. Dr Montano has served as a principal investigator for over 120 clinical trials to evaluate the safety and efficacy of novel therapeutics for indications such as attention-deficit/hyperactivity disorder, major depressive disorder, and many other psychiatric and neurologic conditions. He is an editorial board member of The Primary Care Companion for CNS Disorders.

Alyssa Weers, PharmD (OPDC)
Clinical & Scientific Liaison

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Live Event - Avoiding Burnout: Learning To Live & Work Well In Healthcare
2022-09-29 18:00 - 20:30 (America/New_York) | Mario’s Restaurant, 4222 2nd Ave., Detroit, MI, 48201, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for members of Big Sisters in Nursing.
In this presentation, the objectives are to:

Discuss the incidence and prevalence as well as define burnout and highlight some of the challenges with available data and definitions
Explore some of the biologic, social, and systems-related data pertaining to burnout
Review drivers of burnout as well as strategies to identify and address this challenge

Venue

Featuring

Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison

More

Dr. DiNapoli earned her PhD from the University of Alabama.

Gwendolyn Stockton, PharmD, BCPP
Medical Science Liaison

Speakers Elizabeth DiNapoli, PhD and Gwendolyn Stockton, PharmD, BCPP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Virtual Event - Strategies To Optimize Patient Outcomes In Bipolar I Disorder
2022-09-29 12:00 - 13:00 (America/North_Dakota/New_Salem) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for PsychU members in Alabama and Florida.
Bipolar I Disorder is characterized by mood episode recurrence, which impacts patient functioning and clinical outcomes. During our discussion, speakers will discuss risk factors for mood recurrence including non-adherence. They will also discuss some management strategies including long acting injectables (LAIs) that may optimize patient outcomes.

Featuring

Beau Pender, PharmD
Medical Science Liaison

Rohona Masharak, PHMNP-BC, MSL (OPDC)
Medical Science Liaison

Speakers Beau Pender, PharmD and Rohona Masharak, PHMNP-BC, MSL are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Inadequately Treated Major Depressive Disorder
2022-09-28 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for all PsychU Members.
In this presentation, the objectives are to:

Describe the prevalence of depression in the US
Highlight the burden of MDD
Identify inadequately treated MDD and understand how it impacts patients
Understand which patients are at risk for inadequately treated MDD
Explain MDD treatment strategies

Featuring

Dante Durand, MD, MBA
Vice Chair of Clinical Services & Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine; Chief Medical Officer at Jackson Behavioral Health Hospital in Miami, FL.

More

Dr. Dante Durand is an Associate Professor and the Vice-Chair of Clinical Services for the Department of Psychiatry at the University of Miami Miller School of Medicine. He is also the Chief Medical Officer at Jackson Behavioral Health Hospital. Dr. Durand’s area of clinical and research interest is schizophrenia. He has written several scientific articles and is the principal investigator on multiple clinical trials in this area. As faculty member, Dr. Durand has been involved in the education of future generation of psychiatrists and due to his teaching abilities, he has received multiple honors such as the University of Miami, Department of Psychiatry Senior Teaching Award for 5 consecutive years. Dr. Durand is a fellow of the American Psychiatric Association, a member of the American College of Psychiatrists and a board examiner of the American Board of Psychiatry and Neurology.

Aneta Fornal, PharmD (OPDC)
Medical Science Liaison

Speaker Dante Durand, MD, MBA is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Aneta Fornal, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Quality Matters: An Update From NCQA On Behavioral Health Measurement Trends
2022-09-27 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
The National Committee for Quality Assurance (NCQA) collects information on the performance of health care service delivery from health plans covering more than 191 million people using its proprietary Healthcare Effectiveness Data and Information Set, or HEDIS. One of health care’s most widely used performance improvement tools, HEDIS consists of more than 90 measures over six domains of care. Within the behavioral health market, HEDIS assesses depression screening and follow-up, medication adherence, access, care coordination, opioid overuse, and more.1 NCQA speaker Lyndsey Nguyen provides a review of HEDIS behavioral health measures and updates on the overall performance trends of select measures through the most recent measurement year.

1. HEDIS. (2021, July 15). Retrieved from https://www.ncqa.org/hedis/.

Featuring

Lyndsey Nguyen, MS, BA
Senior Health Care Analyst National Committee for Quality Assurance (NCQA)

More

Lyndsey Nguyen currently serves as a Senior Health Care Analyst in the Performance Measurement Department at the National Committee for Quality Assurance (NCQA). She manages, leads, and coordinates activities related to the development of quality metrics for U.S. health care. Her areas of focus include mental health, substance use, and pain management. Ms. Nguyen holds an M.S. degree in physiology (complementary and alternative medicine) from Georgetown University, and a B.A. in cognitive science from the University of Virginia.

Arden Arslanyan, PharmD
Managed Market Liaison

More

Arden Arslanyan, PharmD, is a Managed Market Liasion with Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Arden has held various clinical roles within Express Scripts supporting Medicare, Commercial, and Workers’ Comp lines of business. He attended Nova Southeastern University and completed a post-doctoral fellowship program in medical information in conjunction with Rutgers and Janssen Scientific Affairs.

Speaker Lyndsey Nguyen, MS, BA is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Arden Arslanyan, PharmD is an employee of employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Live Event - Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
2022-09-21 18:00 - 20:00 (America/New_York) | The Capital Grille – NJ, 2000 Route 38, Cherry Hill, NJ, 08002, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in New Jersey.

Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.

*Note: There is a limited seating capacity of 15 for this event.

Venue

Featuring

Salvatore G. Savatta, MD
Chair of Psychiatry, Trinitas Regional Medical Center, Elizabeth, NJ

More

Dr. Salvatore G. Savatta received his Bachelor of Arts degree in Economics from New York University, graduated from New York University School of Medicine in 2001 and completed his M.S. in Biostatistics Clinical Research Methods at Columbia University’s Mailman School of Public Health in 2005. Dr. Savatta has previously served as Director of Inpatient Psychiatry at New York Methodist Hospital, Medical Director of TMS Centers of America and both Deputy Chair and Interim Chair of Psychiatry at Trinitas Regional Medical Center. He presently serves as Chair of Psychiatry at Trinitas and has done so since May of 2020.
Dr. Savatta completed his Psychiatry Residency at St. Vincent’s Catholic Medical Center and completed a Public Service Psychiatry Fellowship and a Forensic Psychiatry Fellowship at the University of Pittsburgh Medical Center – Western Psychiatric Institute and Clinic. Dr. Savatta is Board Certified in both Adult Psychiatry and Forensic Psychiatry.
He has tailored his clinical practice to focus on “difficult to treat” depression, and often includes the implementation of Neuromodulation techniques such as TMS, Esketamine, and Electroconvulsive Therapy (ECT) when clinically appropriate.

Becky Wong, PharmD, MBA
Medical Science Director

Speaker Salvatore G. Savatta, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Virtual Event - Suicide Awareness, Assessment, & Prevention Strategies
2022-09-21 18:00 - 19:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for PsychU members in Broome, Steuben, Chemung, Tioga, and Tompkins counties, NY.
In this presentation, the objectives are to:

Review common terminology used in suicidology
Elucidate statistics associated with suicide globally and in the United States
Discuss the possible relationship between suicide and psychiatric illnesses: major depressive disorder (MDD), bipolar disorder, and schizophrenia
Highlight various suicide assessment tools
Present current research on the neurobiology of suicide
Provide suicide prevention resources and insight into ongoing research

Featuring

Bennett Doughty, PharmD, BCPS, BCPP
Clinical Assistant Professor, Binghamton University School of Pharmacy and Pharmaceutical Science

More

Dr. Bennett Doughty grew up in Winthrop, Maine, and earned his Doctor of Pharmacy degree with honors from the University of Connecticut School of Pharmacy in 2016. Following graduation, Doughty completed two years of residency training at the VA Connecticut Healthcare System in West Haven, CT specializing in psychiatric pharmacy. He is a Board-Certified Pharmacotherapy Specialist (BCPS) and a Board-Certified Psychiatric Pharmacist (BCPP).

Dr. Doughty joined the Binghamton School of Pharmacy and Pharmaceutical Sciences in 2018 as a clinical assistant professor in the Department of Pharmacy Practice. He also serves as a clinical psychiatric pharmacy specialist at the Guthrie Robert Packer Hospital in Sayre, PA, where he has created an integrated outpatient psychiatric clinic within primary care. Dr. Doughty is the program director of the Binghamton University Opioid Overdose Prevention Program (BU OOPP), the director of Binghamton University’s and SUNY Upstate Medical University’s Rural and Underserved Service Track (TRUST), and a Community-Engaged Teaching Fellow, recognized by the Binghamton University Center for Civic Engagement.

Dr. Doughty’s research interests primarily focus on the engagement of patients in substance use disorder treatment but also have expanded to include focus on interprofessional care in underserved communities.

Sara A. Spencer, PharmD, MS, BCGP
Medical Science Liaison

Speaker Bennett Doughty, PharmD, BCPS, BCPP is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Sara A. Spencer, PharmD, MS, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Defining, Evaluating, & Implementing Digital Health Tools
2022-09-21 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
In this webinar, Dr. Vasan and Dr. Behrens will share their expertise in the areas of digital tools. Together, they will provide definitions of digital health tools and discuss how those tools may help address some unmet needs. They will also provide best practices for digital tool design and clinical validation. Finally, they will explore how to streamline digital tool implementation.

Featuring

Nina Vasan, MD, MBA
Chief Medical Officer of Real; Clinical Assistant Professor of Psychiatry, Stanford University School of Medicine; Founder and Executive Director of "Brainstorm: The Stanford Lab for Mental Health Innovation."

More

Dr. Nina Vasan is a psychiatrist, entrepreneur, and pioneer in digital mental health innovation. She is the Chief Medical Officer of Real, Clinical Assistant Professor of Psychiatry at Stanford University School of Medicine, where she is the Founder and Executive Director of Brainstorm: The Stanford Lab for Mental Health Innovation.

Jake Behrens, MD
CEO & Medical Director, Regional Director
Envision ADHD, Brightside Health

Fatima Sadat, PharmD
Senior Medical Science Liaison

Speakers Nina Vasan, MD and Jake Behrens, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Fatima Sadat is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Live Event - Strategies to Optimize Patient Outcomes in Bipolar Disorder 1
2022-09-14 18:30 - 20:30 (America/New_York) | Fushimi – Williamsburg, 475 Driggs Avenue, Williamsburg, NY, 11211, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Private Event for Healthcare Professionals in Manhattan, Brooklyn, Queens, NY.
Bipolar I Disorder is characterized by mood episode recurrence, which impacts patient functioning and clinical outcomes.1,2 During our discussion, Drs. Erika Modh and Jehan Marino will discuss risk factors for mood recurrence including non-adherence. They will also discuss some management strategies including long acting injectables (LAIs) that may optimize patient outcomes.

Objectives:

Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder

References:

Vaquez GH European Neuropsychopharmacology 2015; 25: 1501-1512
Kapczinski NS, et al. Expert Rev Neurother. 2017;17(3):277-285

Venue

Featuring

Jehan Marino, PharmD, BCPP
Medical Science Director

Erika Modh, PharmD, BCPS
Medical Science Liaison

Speakers Jehan Marino, PharmD, BCPP and Erika Modh, PharmD, BCPS are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Virtual Event - Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
2022-09-14 14:00 - 15:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a National Virtual Event for all PsychU members.
In “Strategies to Optimize Patient Outcomes in Bipolar I Disorder: the Role of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.

Featuring

Martin Guerrero, MD, JD
Forensic and Geriatric Psychiatrist, El Paso, Texas

Jessie Chambers, PhD
Medical Science Liaison

Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

988: What’s The Scoop? A Discussion With Experts In Suicide Prevention & Mental Health
2022-09-13 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
988, the three-digit dialing code developed and designed as a suicide and crisis lifeline, went live on July 16, 2022. Since Congress designated 988 in 2020, there has been a lot of excitement, confusion, and buzz around exactly what this new number means for individuals in crisis, healthcare providers, and our national and local healthcare landscapes. Experts in suicide awareness and prevention, Drs. Christine Moutier and Jonathan Singer, will describe what 988 is and is not as they sit down with PsychU’s Rachel Self in our September webinar event. Details will be provided on some of the myths and misconceptions surrounding 988, how it will impact HCPs and individuals in crisis upon rollout and in the years to come. Our experts will share insights on nationwide and state-specific efforts and gaps with respect to 988, and what this means for healthcare providers and individuals in crisis. Finally, we will highlight how 988 could evolve over time to shape our mental healthcare environment and the role healthcare providers can play to make positive changes at their local and regional levels.
Join us for an exciting and informative dialogue on the unfolding story surrounding 988 in September!

Featuring

Christine Yu Moutier, MD
Esteemed psychiatrist, Chief Medical Officer of The American Foundation for Suicide Prevention, and PsychU MDD Section Advisor.

More

Christine Yu Moutier is a leader in the field of suicide prevention who joined AFSP in 2013. It is through her passion and commitment to the work that we see a lasting impact via research, education and support to communities across the U.S.

She has testified before the U.S. Congress and provided multiple Congressional briefings on suicide prevention, presented to the White House, spoken at the National Academy of Sciences, she co-anchored CNN’s Finding Hope suicide prevention town hall, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, Anderson Cooper 360, the BBC, CNN, NBC and other print and television outlets.

Throughout her career she has focused on training healthcare leaders, physicians, and patient groups in order to change the healthcare system’s approach to mental health, fighting stigma and optimizing care for those suffering from mental health conditions. In addition to co-founding AFSP’s San Diego Chapter, Moutier co-led a successful suicide prevention and depression awareness program for health science faculty, residents, and students, which featured AFSP’s groundbreaking Interactive Screening Program.

Since earning her medical degree and training in psychiatry at the University of California, San Diego, Moutier has been a practicing psychiatrist, professor and dean in the UCSD School of Medicine, medical director of the Inpatient Psychiatric Unit at the VA Medical Center in La Jolla, and has been clinically active with diverse patient populations, such as veterans, Asian refugee populations, as well as physicians and leaders with mental health conditions. She also served as co-investigator for the Sequenced Treatment Alternatives to Relieve Depression study (STAR*D), a large National Institute of Mental Health trial on the treatment of refractory depression.

Moutier has authored articles and book chapters for publications such as the Journal of the American Medical Association, Academic Medicine, the American Journal of Psychiatry, the Journal of Clinical Psychiatry, Psychiatric Times, Depression and Anxiety, Academic Psychiatry, and most recently co-authored Stahl’s Clinical Handbook: Suicide Prevention Edition.

Jonathan Singer, PhD, LCSW
Esteemed author and scholar, with expertise in suicide prevention and social worker. He serves as Professor at Loyola University’s School of Social Work, is an emeritus president of the Association of Suicidology, founder & host of the Social Work podcast, as well as PsychU speaker & collaborator.

More

Jonathan B. Singer, Ph.D., LCSW is a Professor of Social Work at Loyola University Chicago, Past-President of the American Association of Suicidology and coauthor of the 2015 Routledge text, Suicide in Schools: A Practitioner’s Guide to Multi-level Prevention, Assessment, Intervention, and Postvention.

Jonathan is a leader in the field of suicide awareness and prevention who has been a member and former president of the American Association of Suicidology since 2005. It is through his passion and commitment to the field of social work and suicide prevention that we see a lasting impact via education, social media, and support to communities across the U.S.

He is a two-time winner of the National Association of Social Workers Media Award (2012 and 2016). He was a 2014 Visiting Scholar at Fordham University, the 2017 Lucille N. Austin Scholar at Columbia University, and the 2018 Distinguished Lecturer at Weber State University.

Dr. Singer is a well-regarded international speaker who has given hundreds of continuing education workshops, keynote addresses, and presentations on youth suicide, ethics, technology, adolescent development and attachment-based family therapy in the USA, Latin America, Asia, and Europe.

He is the author of over 75 publications and his research has been featured in national and international media outlets like NPR, BBC, Fox, Time Magazine, and The Guardian. His co-authored article with Arielle Sheftall and John Ackerman about the news media’s reporting on the suicide deaths of Kate Spade and Anthony Bourdain won the prestigious 2019 SDX prize for research on journalism. He is an NASW Expert, Healio Psychiatry Peer Perspective Board member, and on several national youth advisory boards including Sandy Hook Promise, JED Foundation, Suicide Prevention Resource Center, and the National Suicide Prevention Lifeline.

A pioneer in the integration of technology and social work, Dr. Singer is an original member of the online suicide prevention social media community #SPSM, past-Treasurer for the international human services Information Technology association (http://husita.org/), co-lead for the Social Work Grand Challenge initiative “Harness Technology for Social Good” (https://grandchallengesforsocialwork.org/harness-technology-for-social-good/), and member of CSWE’s Technology Advisory Group.

Dr. Singer is the founder and host of the award-winning Social Work Podcast (www.socialworkpodcast.com), the first podcast by and for social workers. The Social Work Podcast has over 40,000 followers on social media, listeners in 208 countries and territories, and a million podcast episode downloads per year. He lives in Evanston, IL with his wife and three children and can be found on Twitter as @socworkpodcast and Facebook at facebook.com/swpodcast.

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

More

Rachel Self, PhD, MS is a Medical Science Director for Otsuka’s Neuroscience Field Medical Affairs, neuroscientist, & wellness advocate.

Speakers Christine Yu Moutier, MD and Jonathan Singer, PhD, LCSW are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Live Event - Suicide Awareness, Assessment, & Prevention Strategies
2022-09-12 18:30 - 20:00 (America/North_Dakota/New_Salem) | Flemming’s Steakhouse, 103 Summit Blvd, Birmingham, AL, 35243, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in the Birmingham, AL area.
This presentation will look at multiple aspects pertaining to suicide awareness, assessment, and prevention strategies. We will start by discussing common terminology used in suicidology, move to the prevalence globally and within the US, transition to the possible relationships between suicide and psychiatric illnesses, and end with conversations around assessment tools and additional resources for patients and caregivers. This presentation is intended to facilitate conversations around suicide and mental health and help identify opportunities within local communities for collaborative partnerships.

Venue

Featuring

Marshall Cates, PharmD, BCPP, FASHP, FCCP, FALSHP
Professor & Chair Department of Pharmacy Practice

Beau Pender, PharmD
Medical Science Liaison

Speaker Marshall Cates, PharmD is a paid consultant for Speaker is an employee of

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Virtual Event - Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
2022-09-07 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for PsychU members in D.C., Maryland, North Carolina, South Carolina and Virginia.
In “Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.

Featuring

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Miranda Fisher, PhD
Medical Science Liaison

Speakers Dennis Sholler, PhD; Amica Simmons-Yon, PharmD, PhD; and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Panel Discussion On The Role Of Psychotherapy, Cognitive Training, & Digital Platforms For Treatment Of Major Depressive Disorder
2022-08-30 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
Psychotherapy, particularly cognitive behavioral therapy, is a widely accepted and effective treatment approach for major depressive disorder.1 Cognitive training represents a promising and novel therapeutic intervention to address cognitive and affective symptoms of depression.2 Individual and systematic barriers may limit initiation and adherence to psychological interventions.3 Digital platforms may be one potential solution to improve access to treatment, lessen concerns about social stigma, and ease the cost burden.4 Our panel of experts will engage in an exciting discussion on the role of psychotherapy, cognitive training, and digital platforms for treatment of major depressive disorder.

References:

Gelenberg AJ et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2010. Accessed on 3/4/2021 at: PG_Depression3e.book(PG_Depression_3e00Pre.fm) (psychiatryonline.org)
Woolf, C., et al. Neuropsychol Rev. 2022 Jun; 32(2):419-437. A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder – PubMed (nih.gov)
Mohr, D. C. et al. Journal of Clinical Psychology, 2010; 66(4): 394-409. And Lau Y et al. J Psychiatr Res. 2022;146:234–248.
Wright JH, Mishkind M. Focus (Am Psychiatr Publ). 2020;18(2):162–168.

Featuring

Saundra Jain, MA, PsyD, LPC
Adjunct Clinical Affiliate for the School of Nursing at the University of Texas, Austin; Co-founder of WILD-5 Wellness®

More

Saundra Jain is an Adjunct Clinical Affiliate for the School of Nursing at The University of Texas, Austin, Texas. She is very focused on wellness and the impact of positive psychology on client outcomes. She launched a private practice of psychotherapy where she currently provides services for a wide range of mental health issues.

Dr. Jain is a co-creator of the WILD 5 Wellness Program, which combines five elements of wellness (exercise, mindfulness, sleep, social connectedness, and nutrition) into a prescriptive, easy-to-follow wellness program. She is very active in the area of peer-to-peer education, especially in the disease states of depression, bipolar disorder, anxiety disorders, and ADHD. She is the co-creator and co-presenter of a novel interactive workshop addressing the challenges of dealing with psychiatric co-morbidities through the use of psychiatric scales and screeners. She also serves as a member of the Psych Congress Committee providing direction regarding educational gaps & needs for healthcare practitioners in the world of mental health.

Co-founder WILD-5 Wellness®

Gaurava Agarwal, MD
Chief wellness executive, Northwestern Medicine
Director of Faculty Wellness, Northwestern University

More

Gaurava Agarwal, MD serves as the Major Depressive Disorder Section Advisor for PsychU. In addition, he is the Chief Wellness Executive, Northwestern Medicine Medical Groups; Associate Professor for the Department of Psychiatry and Behavioral Science and Medical Education, and Director of Medical Student Education in Psychiatry at Northwestern University’s Feinberg School of Medicine. He also is the Director of Physician Well-Being for Northwestern Medicine’s Medical Groups.

Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison

More

Dr. DiNapoli earned her PhD from the University of Alabama.

Speakers Saundra Jain, MA, PsyD, LPCand Gaurava Agarwal, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Elizabeth DiNapoli, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Distinguishing Sedation From Efficacy In Antipsychotic Treatment
2022-08-18 21:30 - 22:30 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for PsychU members in Arizona; Las Vegas, Nevada; and San Diego, Imperial, Riverside and San Bernardino Counties, CA.
In this presentation, the objectives are to:

Recognize the symptoms of acute agitation in an emergency department setting
Understand the potential importance of minimizing sedation in the treatment of acute agitation in patients with schizophrenia
Distinguish sedation from efficacy in antipsychotic treatment
Understand the physiologic mechanisms for sedation and pharmacologic considerations when selecting an antipsychotic

Featuring

Michael Aldape, PhD
Senior Medical Science Liaison

John Awad, MD (OPDC)
Senior Medical Science Liaison

Speakers John Awad, MD, BPharm and Michael Aldape, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Distinguishing Sedation From Efficacy In Antipsychotic Treatment
2022-08-18 12:00 - 13:00 (America/Los_Angeles) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for PsychU members in Arizona; Las Vegas, Nevada; and San Diego, Imperial, Riverside and San Bernardino Counties, CA.
In this presentation, the objectives are to:

Recognize the symptoms of acute agitation in an emergency department setting
Understand the potential importance of minimizing sedation in the treatment of acute agitation in patients with schizophrenia
Distinguish sedation from efficacy in antipsychotic treatment
Understand the physiologic mechanisms for sedation and pharmacologic considerations when selecting an antipsychotic

Featuring

Laura Brennan, PhD (OPDC)
Medical Science Liaison

John Awad, MD (OPDC)
Senior Medical Science Liaison

Speakers John Awad, MD, BPharm and Laura Brennan, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Implementing Technology Into The Management Of Patients With Mental Health Disorder
2022-08-16 13:00 - 14:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for all PsychU members.
In this presentation, the objectives are to:

Review current digital health developments in psychiatry and areas in which technology can be used in clinical practice
Consider advantages and challenges of using digital tools in mental health care
Discuss approaches and challenges to implementation and adoption of digital technology in the mental health clinic

Featuring

Robert N. Cuyler, PhD
Chief Clinical Officer, Freespira, Inc

More

Robert N. Cuyler, PhD serves as Chief Clinical Officer of Freespira, Inc. With decades of experience as a practicing clinical psychologist, healthcare executive, and consultant, he supervises clinical operations of the company, heads research initiatives, and represents Freespira in conference, publication, and media outlets. In his clinical practice, he focuses on treatment of anxiety, panic conditions, and depression as well as health psychology. Dr. Cuyler received his Ph.D. in Psychology from Louisiana State University and Post-Doctoral Fellowship at the Menninger Foundation.

His consulting and management activities have focused on solving access problems in behavioral health, with a concentration on incorporating telemedicine and healthcare technology into clinical practice. He is author (with Dutch Holland, PhD) of the book Implementing Telemedicine: Completing Projects On Target On Time On Budget. He has authored or co-authored four textbook chapters on telemedicine, including the recently published second edition of the book Emergency Psychiatry.

He previously served as President of the Association for Ambulatory Behavioral Healthcare. His numerous public policy activities have included membership on the Texas Hospital Association’s Psychiatric Advisory Council, and member of the National Institute of Mental Health’s National Mental Health Leadership Council. Dr. Cuyler has served for over a decade as a judge at the Rice University’s Jones School annual Business Plan Competition.

Dennis Pabis, PharmD, BCPP (OPDC)
Senior Medical Science Liaison

Speaker Robert N. Cuyler, PhD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Dennis Pabis, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis
2022-08-09 18:30 - 19:30, 2022-08-09 12:00 - 13:00 (America/Los_Angeles) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for PsychU members in the San Diego, Imperial, Riverside, San Bernardino, Long Beach, Los Angeles, and Bakersfield Counties, CA.
In this presentation, the objectives are to:

Provide a brief overview of depression prevalence and current standard treatments
Review the monoamine hypothesis of depression
Discuss alternative hypotheses of depression
Highlight potential new therapeutic intervention targets

Featuring

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Elika Hefazi, PharmD, BCPP
Medical Science Liaison

Speakers Sucharita Somkuwar, PhD, BPharm and Elika Hefazi, PharmD, BCPP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

A Conversation With An Expert In Agitation In Alzheimer’s Dementia, A Person With Lived Experience, & A Care Partner
2022-08-02 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
Alzheimer’s dementia is highly prevalent, under-diagnosed, and predicted to increase significantly in the coming decades due to an aging population. Unfortunately, a large proportion of individuals with Alzheimer’s disease (AD) also experience neuropsychiatric symptoms, such as agitation, depression, apathy, and hallucinations. In this webinar, our panelist will be reviewing the epidemiology of AD and accompanying neuropsychiatric symptoms with a focus on agitation. Dr. Jeffery Cummings will have a conversation with two individuals who have unique perspectives on the clinical presentation and experience of agitation in AD. Laurie Scherrer is an individual with early onset AD* and Roy Scherrer is a care partner. The webinar will also provide the most recent definition of agitation from the International Psychogeriatric Association (IPA) and highlight clinically validated rating scales to assess agitation in AD.

*This webinar presents one person’s individual experience with dementia and may differ from the presentation experienced by others with Alzheimer’s dementia or other dementia disorders.

Featuring

Jeffrey Cummings, MD, ScD
Professor of Neurology, Cleveland Clinic Lou Ruvo Center for Brain Health

More

Jeffrey Cummings, MD, ScD, is Joy Chambers-Grundy Professor of Brain Science, Vice Chair for Research and Director of the Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School for Integrated Health Sciences, UNLV. Dr Cummings is an expert clinical trialist and leader in drug development for Alzheimer’s disease. He has published over 750 peer-reviewed scientific articles and 40 books on Alzheimer’s disease, clinical trials and related topics. His achievements have been recognized by many awards, including the Bengt Winblad Lifetime Achievement Award of the Alzheimer’s Association; the Lifetime Achievement Award of the Society for Cognitive and Behavioral Neurology; the Distinguished Scientist Award of the American Association of Geriatric Psychiatry; the Leadership and Achievement Award of the International Society for CNS Drug Development; and the Melvin Goodes Prize of the Alzheimer’s Drug Discovery Foundation.

Laurie Scherrer
Individual with Early Onset Alzheimer’s Disease

More

Laurie Scherrer was diagnosed with early onset Alzheimer’s & Frontotemporal Dementia in August of 2013 at the age of 55. Laurie had a career as a banking executive and sales professional. Unable to continue her professional career, Laurie turned her focus towards helping others living with dementia. She is a Dementia Mentor and provides peer support to several people living with dementia. Laurie created and is the co-producer of the Dementia Action Alliance’s (DAA) monthly podcast, Professional Insights, and its online weekly discussion program, Dementia Discussions. Laurie serves on DAA’s Board of Directors and Advisory Board. Besides being a sought-after international speaker, Laurie is involved in countless advocacy projects. Lil Dawg is Laurie’s frequent companion and support dog. She is currently 64 years old.

Roy Scherrer
Care Partner to an Individual with Early Onset Alzheimer’s Disease

More

Roy Scherrer worked as a Production Planner until 2018 when he retired from his job to work on Laurie’s “Honey Do List”. His plumbing, electrical and carpentry skills are kept busy with changes to their new home. Even today, Roy and Laurie continuously work to identify triggers that cause her confusion and agitation and find strategies to support changing abilities. Roy is currently 71 years old and is living with common variable immunodeficiency. He and Laurie have been married for over 40 years.

Mike Crooks, PharmD, BCGP
Senior Long-Term Care Medical Science Liaison

Jeffrey Cummings, MD, ScD, Laurie Scherrer, and Roy Scherrer are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.Mike Crooks is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Digital Health Tools: Combating Stigma & Healthcare Disparities
2022-07-28 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
Dr. Velligan and Dr. Pederson will share their expertise in the areas of digital tools, stigma, and healthcare disparities. Together, they will provide an overview of stigma and healthcare disparities in mental health treatment, and then discuss digital tools used in the treatment of mental illness. Finally, we will explore how digital health technology could combat healthcare disparities.

Featuring

Dawn Velligan, PhD
Director, Division of Community Recovery, Research Training, University of Texas Health Science Center, San Antonio, TX

Aderonke Pederson, MD
Director of Research Equity in the Clinical Trials Network and Institute at Massachusetts General Hospital (MGH) and a Member of the Faculty of Psychiatry at Harvard Medical School

Simon Kim, PharmD
Medical Science Liaison

Speakers Dawn Velligan, PhD and Aderonke Pederson, MD are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Simon Kim is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Live Event - Mental Health Wellness: Addressing Health Care Professional Burnout During Uncertain Times
2022-07-27 18:00 - 19:00 (America/New_York) | The Bri Mari, 119 South Elmer Ave., Sayre, PA, 18840, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in Bradford County PA, Tioga County PA, Chemung County NY, Broome County NY, and Steuben County NY.
The COVID-19 pandemic has exerted substantial effects on mental health. The speaker will discuss the dynamics of mental health and the potential impacts of a pandemic or other extreme stressors that may result in healthcare professional burnout. Speakers will also explore a stress continuum model, sources of stress, and highlight strategies for health care professionals to establish and maintain wellness, build resilience, and engage in healthy self-care.

Venue

Featuring

Bennett Doughty, PharmD, BCPS, BCPP
Clinical Assistant Professor, Binghamton University School of Pharmacy and Pharmaceutical Science

More

Dr. Bennett Doughty grew up in Winthrop, Maine, and earned his Doctor of Pharmacy degree with honors from the University of Connecticut School of Pharmacy in 2016. Following graduation, Doughty completed two years of residency training at the VA Connecticut Healthcare System in West Haven, CT specializing in psychiatric pharmacy. He is a Board-Certified Pharmacotherapy Specialist (BCPS) and a Board-Certified Psychiatric Pharmacist (BCPP).

Dr. Doughty joined the Binghamton School of Pharmacy and Pharmaceutical Sciences in 2018 as a clinical assistant professor in the Department of Pharmacy Practice. He also serves as a clinical psychiatric pharmacy specialist at the Guthrie Robert Packer Hospital in Sayre, PA, where he has created an integrated outpatient psychiatric clinic within primary care. Dr. Doughty is the program director of the Binghamton University Opioid Overdose Prevention Program (BU OOPP), the director of Binghamton University’s and SUNY Upstate Medical University’s Rural and Underserved Service Track (TRUST), and a Community-Engaged Teaching Fellow, recognized by the Binghamton University Center for Civic Engagement.

Dr. Doughty’s research interests primarily focus on the engagement of patients in substance use disorder treatment but also have expanded to include focus on interprofessional care in underserved communities.

Sara A. Spencer, PharmD, MS, BCGP
Medical Science Liaison

Speaker Bennett Doughty, PharmD, BCPS, BCPP is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Sara A. Spencer, PharmD, MS, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Virtual Event - Inadequately Treated Major Depressive Disorder
2022-07-27 12:00 - 13:00 (America/North_Dakota/New_Salem) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
This is a Virtual Event for all PsychU members.
In this presentation, the objectives are to:

Describe the prevalence of depression in the US
Highlight the burden of MDD
Identify inadequately treated MDD and understand how it impacts patients
Understand which patients are at risk for inadequately treated MDD
Explain MDD treatment strategies

Featuring

Rodrigo Machado-Vieira, MD, PhD, MSc
Professor of Psychiatry & Behavioral Sciences & Director of the Experimental Therapeutics & Molecular Pathophysiology Program (ETP), Faillace Department of Psychiatry & Behavioral Sciences, UTHealth – Houston

Dennis Pabis, PharmD, BCPP (OPDC)
Senior Medical Science Liaison

Speaker Rodrigo Machado-Vieira, MD, PhD, MSc is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Dennis Pabis, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

The Effects Of Racism On The Mental Healthcare Community: How Marginalized Patients & Providers Are Impacted
2022-07-21 12:00 - 13:00 (America/New_York) | MA
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Collaborative Care In Mental Health
As a community, we know that the effects of racism are not confined to patients alone–but can impact mental health professionals. This webinar will highlight some of the barriers that healthcare professionals experience, including Black, Indigenous, People of Color (BIPOC) and other marginalized groups. Our presenters will also discuss the impact of racism on accessing mental health services and the strategies the health care and research communities are implementing to address some of these challenges. In honor of National Minority Mental Health Month, PsychU has invited Drs. Napoleon Higgins & Gonzalo Gonzalez to share their expertise on these critical issues.

Featuring

Napoleon Higgins, MD
Psychiatrist, Bay Pointe Behavioral Health Services;
Former President, Black Psychiatrists of America

Gonzalo Gonzalez, DNP, APRN, NP-C
Nephrology Clinical & Scientific Liaison

Becky Wong, PharmD, MBA
Medical Science Director

Napoleon Higgins, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.Gonzalo Gonzalez, DNP, APRN, NP-C is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.Becky Wong, PharmD, MBA is an employee of employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Live Event - Mental Health Wellness: Addressing Health Care Professional Burnout During Uncertain Times
2022-07-19 18:00 - 20:30 (America/New_York) | VKI Japanese Steakhouse, 1004 Old Mill Run, The Villages, FL, 32162, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Private Event for LifeStream Behavioral Center.
The COVID-19 pandemic has exerted substantial effects on mental health. The speakers will discuss the dynamics of mental health and the potential impacts of a pandemic or other extreme stressors that may result in healthcare professional burnout. Speakers will also explore a stress continuum model, sources of stress, and highlight strategies for health care professionals to establish and maintain wellness, build resilience, and engage in healthy self-care.

Venue

Featuring

Sue Smith, PharmD (OPDC)
Clinical & Scientific Liaison

Walter Lawhorn, PharmD (OPDC)
Regional Medical Lead

Speakers Sue Smith, PharmD and Walter Lawhorn, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Live Event - Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
2022-07-13 18:00 - 21:00 (America/Los_Angeles) | Primo Grill, 2701 6th Ave, Tacoma, WA, 98406, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Live Event for PsychU members in Western Washington state.
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.

Venue

Featuring

Chet Robachinski, MD
Psychiatric Director, Bailey-Boushay House, Seattle, WA; Founding Partner, Associates in Behavioral Health

Simon Kim, PharmD
Medical Science Liaison

Speaker Chet Robachinski, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Simon Kim, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Joint Live Event - Major Depressive Disorder (MDD) in Chronic Kidney Disease (CKD)
2022-07-12 18:30 - 20:30 (America/Los_Angeles) | Eight4Nine Restaurant & Lounge, 849 North Palm Canyon Drive, Palm Springs, CA, 92262, United States
Home

Events

About This Event

Collaborative Care In Mental Health
This is a Joint Live Event, sponsored by PsychU and NephU, for Primary Care/Internal Medicine, Psychiatrists and Nephrologists in the Palm Springs, CA area.
There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD.

Venue

Featuring

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Marla Dallal, PharmD, RPH
Clinical & Scientific Liaison (Nephrology)

More

Marla Dallal, PharmD, RPH is a Clinical & Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy in Los Angeles. While in pharmacy school, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.

Speakers Sucharita Somkuwar, PhD, BPharm and Marla Dallal, PharmD, RPH are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.
